| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028528361 |
| P356 | DOI | 10.1186/1472-6874-8-1 |
| P932 | PMC publication ID | 2254595 |
| P698 | PubMed publication ID | 18194511 |
| P5875 | ResearchGate publication ID | 5656022 |
| P50 | author | Eiliv Lund | Q11966779 |
| Marit Waaseth | Q51168354 | ||
| Yngve Figenschau | Q117006935 | ||
| P2093 | author name string | Vanessa Dumeaux | |
| Charlotta Rylander | |||
| Kjersti Bakken | |||
| Karina S Olsen | |||
| P2860 | cites work | Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women | Q45188730 |
| Standardization of steroid hormone assays: why, how, and when? | Q46046764 | ||
| Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density | Q46432720 | ||
| Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones | Q46446109 | ||
| Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). | Q46495873 | ||
| Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women | Q46609173 | ||
| Body image and obesity: effects of gender and weight on perceptual measures of body image | Q47295315 | ||
| Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women. | Q50994445 | ||
| Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort. | Q51956846 | ||
| Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms. | Q52074501 | ||
| External validity in a population-based national prospective study--the Norwegian Women and Cancer Study (NOWAC). | Q52958893 | ||
| Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study. | Q55038814 | ||
| Sex hormone levels and risk of cardiovascular events in postmenopausal women | Q28165327 | ||
| Estrogen carcinogenesis in breast cancer | Q28292500 | ||
| Invited commentary: the art of making questionnaires better | Q30483266 | ||
| Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution | Q33909569 | ||
| Breast cancer and hormone-replacement therapy in the Million Women Study | Q34223870 | ||
| Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort | Q34552706 | ||
| Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study | Q34576753 | ||
| Anthropometric measurements and body silhouette of women: validity and perception | Q36063058 | ||
| Cohort profile: The Norwegian Women and Cancer Study--NOWAC--Kvinner og kreft | Q36888458 | ||
| Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet | Q39368721 | ||
| Health hazards in middle-aged women with cardiovascular disease: a case-control study of swedish women. the women's health in the Lund area (WHILA) study | Q40222641 | ||
| Bioavailability of oestradiol from the Alora (0.1 mg/day) oestradiol matrix transdermal delivery system compared with Estraderm (0.1 mg/day). | Q42639211 | ||
| Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study | Q42694203 | ||
| Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy | Q43339570 | ||
| Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones | Q43580795 | ||
| Comparison of estrogen and androgen levels after oral estrogen replacement therapy. | Q43853257 | ||
| Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies | Q43963634 | ||
| Hormone stability in human whole blood | Q44359891 | ||
| Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women | Q44472863 | ||
| The validity of self-reported use of hormone replacement therapy among Danish nurses | Q44826327 | ||
| Menopause transition: Annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause. | Q44924316 | ||
| The validity of self-reported use of hormone replacement therapy among Danish nurses | Q57300844 | ||
| Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment | Q57560086 | ||
| Enterohepatic Cycling and Pharmacokinetics of Oestradiol in Postmenopausal Women | Q59485398 | ||
| Serum Estradiol-Binding Profiles in Postmenopausal Women Undergoing Three Common Estrogen Replacement Therapies | Q61699811 | ||
| Effect of transport conditions on the stability of biochemical markers in blood | Q69392851 | ||
| Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women | Q71513880 | ||
| Circulating hormone levels in menopausal women receiving different hormone replacement therapy regimens. A comparison | Q71514078 | ||
| A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density | Q72243376 | ||
| Delayed assessment of serum and whole blood estradiol, progesterone, follicle-stimulating hormone, and luteinizing hormone kept at room temperature or refrigerated | Q73134991 | ||
| Comparing the sensitivities and specificities of two diagnostic procedures performed on the same group of patients | Q73372209 | ||
| Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women | Q77323455 | ||
| The endocrine transition around menopause--a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women | Q78048946 | ||
| Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women | Q79182457 | ||
| Collection, processing, and storage of biological samples in epidemiologic studies: sex hormones, carotenoids, inflammatory markers, and proteomics as examples | Q80293398 | ||
| Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997 | Q80463428 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Hormone Replacement Therapy | Q108667313 |
| P304 | page(s) | 1 | |
| P577 | publication date | 2008-01-14 | |
| P1433 | published in | BMC Women's Health | Q15762590 |
| P1476 | title | Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis | |
| P478 | volume | 8 |
| Q35203718 | A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis |
| Q36602044 | Association of Serum Sex Hormones with Hemostatic Factors in Women On and Off Hormone Therapy: The Multiethnic Study of Atherosclerosis |
| Q34222445 | Dairy consumption and calcium intake and risk of breast cancer in a prospective cohort: the Norwegian Women and Cancer study |
| Q28473179 | Deciphering normal blood gene expression variation--The NOWAC postgenome study |
| Q36675505 | Estimating Time-Varying PCB Exposures Using Person-Specific Predictions to Supplement Measured Values: A Comparison of Observed and Predicted Values in Two Cohorts of Norwegian Women |
| Q36529006 | Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features |
| Q36643079 | Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study |
| Q37216744 | High serum testosterone levels are associated with excessive erythrocytosis of chronic mountain sickness in men. |
| Q36578173 | Hypothalamic orexin's role in exacerbated cutaneous vasodilation responses to an anxiogenic stimulus in a surgical menopause model |
| Q87886558 | Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study |
| Q44133594 | Metabolic and hormonal parameters in post-menopausal women 10 years after transdermal oestradiol treatment, alone or combined to micronized oral progesterone. |
| Q38090489 | Ovarian epithelial tumors and reproductive factors: a systematic review |
| Q40370438 | Physical activity and risk of endometrial cancer in the Norwegian Women and Cancer (NOWAC) study |
| Q37717233 | Physical activity and the risk of postmenopausal breast cancer - the Norwegian Women and Cancer Study |
| Q34794855 | Plasma fatty acid ratios affect blood gene expression profiles--a cross-sectional study of the Norwegian Women and Cancer Post-Genome Cohort |
| Q45786935 | Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women |
| Q35755138 | Relationship between bone mineral density, its associated physiological factors, and tooth loss in postmenopausal Korean women |
| Q61786722 | Sex Hormones in Postmenopausal Women Receiving Low-Dose Hormone Therapy: The Effect of BMI |
| Q33858917 | Sex hormones and gene expression signatures in peripheral blood from postmenopausal women - the NOWAC postgenome study |
| Q49601287 | Sex-related differences in oxidative stress and neurodegeneration |
| Q97643514 | Targeted pharmacological therapy restores β-cell function for diabetes remission |
| Q48194878 | Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy. |
| Q91651082 | Use of skincare products and risk of cancer of the breast and endometrium: a prospective cohort study |
| Q35193826 | Using blood gene signatures for assessing effects of exposure to perfluoroalkyl acids (PFAAs) in humans: the NOWAC postgenome study. |
| Q46079155 | Vitamin D status and PUFA ratios in a national representative cross-section of healthy, middle-aged Norwegian women—the Norwegian Women and Cancer Post-Genome Cohort |
| Q44525493 | Vitamin D-effective solar UV radiation, dietary vitamin D and breast cancer risk |
| Q34771529 | Weight loss increases follicle stimulating hormone in overweight postmenopausal women [corrected]. |
Search more.